Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 106.19M | 112.67M | 97.07M | 63.90M | 67.09M | 20.53M |
Gross Profit | 20.64M | 24.49M | 13.48M | 24.11M | 23.39M | 3.53M |
EBITDA | -29.91M | -11.17M | -61.65M | -35.26M | 9.69M | -27.41M |
Net Income | -35.26M | -21.09M | -67.21M | -44.32M | 2.39M | -48.15M |
Balance Sheet | ||||||
Total Assets | 44.30M | 160.01M | 130.27M | 141.94M | 80.22M | 11.00M |
Cash, Cash Equivalents and Short-Term Investments | 5.38M | 6.72M | 15.99M | 4.12M | 25.18M | 351.00K |
Total Debt | 183.45M | 21.70M | 27.86M | 19.33M | 9.34M | 101.08M |
Total Liabilities | 222.56M | 57.28M | 51.41M | 72.66M | 43.66M | 139.11M |
Stockholders Equity | -170.65M | 93.28M | 78.86M | 71.76M | 36.56M | -123.97M |
Cash Flow | ||||||
Free Cash Flow | -19.49M | -41.65M | -68.22M | -100.60M | -29.43M | -1.20M |
Operating Cash Flow | -17.04M | -39.67M | -67.39M | -96.14M | -29.40M | -1.01M |
Investing Cash Flow | 853.00K | 5.03M | -775.00K | -5.65M | -51.00K | -208.00K |
Financing Cash Flow | 17.93M | 26.04M | 80.09M | 81.81M | 54.47M | -859.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | HK$3.97B | 6.50 | 16.20% | 15.15% | 1.42% | -8.76% | |
81 Outperform | HK$303.37M | 3.15 | 8.86% | 7.04% | 2.04% | 8.36% | |
78 Outperform | $1.51T | 43.78 | 14.98% | ― | 38.46% | 72.44% | |
59 Neutral | $46.61B | 11.40 | 9.94% | 6.81% | 1.39% | -21.74% | |
55 Neutral | HK$64.46B | -1.91 | -1.90% | 7.21% | -4.17% | -13.99% | |
45 Neutral | HK$33.75M | ― | -80.09% | ― | 8.14% | 70.74% | |
44 Neutral | HK$8.13B | ― | -13.67% | 1.26% | -3.39% | -868.11% |